The emerging treatment of the medication represents a exciting breakthrough in the management of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide affects dual pathways – GLP-1 and the GIP hormone https://tirzepatidepeptide909216.blog-eye.com/42357797/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment